According to the recent study the custom antibody market is projected to reach an estimated $0.8 billion by 2028 from $0.5 billion in 2023, at a CAGR of 10.4% from 2023 to 2028. Growth in this market is primarily driven by increasing government funding investments for research and development activities, rise in therapeutics of antibodies, and growing demand for protein therapeutics.

A more than 150 – page report is developed to understand trends, opportunities and forecast in custom antibody market by service (antibody development, antigen preparation, immunization & hybridoma production, antibody characterization, antibody production & purification, and others), type (monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others), application (research and therapeutics), end use industry (pharmaceutical & biotechnological companies, academic & research institutes, and others), and region.

Download sample report by clicking on below link https://www.lucintel.com/custom-antibody-market.aspx

“Antibody development market is expected to remain the largest segment during the forecast period.”

Based on service, the custom antibody market is segmented into antibody development, antigen preparation, immunization & hybridoma production, antibody characterization, antibody production & purification, and others. Lucintel forecasts that the antibody development market is expected to remain the largest segment due to increasing incidence of chronic diseases and rising investment in R&D activities by the market players.

“Within the custom antibody market, the therapeutics segment is expected to remain the largest application”

Based on application the therapeutics segment is expected to witness the highest growth over the forecast period due to growing investment in the development of novel therapeutics.

“North America will dominate the custom antibody market in near future”

North America is expected to remain the largest segment over the forecast period due to increasing concern over catalog antibodies, growing number of cancer research and genomics research program, and presence of major companies in the region.

Download Brochure of this report by clicking on https://www.lucintel.com/custom-antibody-market.aspx

Major players of custom antibody market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Abcam, Cell Signaling Technology, Bio-Rad Laboratories, GenScript, and Rockland Immunochemicals are among the major custom antibody providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/custom-antibody-market.aspx  or helpdesk@lucintel.com